This Pentacel market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.
The growth observed in the historic period can be attributed to several factors, including the rising demand for pediatric vaccines, efforts to reduce the number of injections, increased awareness of vaccine-preventable diseases, government and public health initiatives, and advancements in combination vaccine technology.
The growth anticipated in the forecast period can be attributed to factors such as the expansion of global vaccination coverage, a stronger focus on comprehensive immunization programs, the growing prevalence of vaccine-preventable diseases, technological advancements in vaccine development, and increased government funding and support for childhood immunization. Key trends during this period include the expansion of combination vaccine offerings, the increasing integration of digital health technologies, growing partnerships between pharmaceutical companies and governments, a rise in public-private collaborations for vaccine distribution, and a heightened focus on pediatric healthcare initiatives.
The growing prevalence of tetanus is expected to drive the growth of the Pentacel market. Tetanus cases have been rising due to factors such as insufficient immunization coverage, inadequate wound care, and limited access to healthcare in rural and underserved regions. Pentacel plays a crucial role in preventing tetanus by providing vaccination against the tetanus toxin through its combination of diphtheria, tetanus, and pertussis (DTaP) components, which stimulate the immune system to generate protective antibodies. In 2023, the World Health Organization reported around 21,830 cases of tetanus worldwide, a sharp increase from 6,705 cases in 2022. As a result, the rising prevalence of tetanus is contributing to the growth of the Pentacel market.
The increasing demand for combination vaccines is expected to further fuel the Pentacel market’s growth. Combination vaccines, which combine multiple components into one shot, offer protection against several diseases at once. Their popularity is growing due to the convenience of reducing the number of required injections, improving vaccination adherence, and offering more cost-effective options. Pentacel, as a combination vaccine, provides protection against five diseases, diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib) in a single shot, simplifying the vaccination process for children. In 2023, the UK’s National Health Service reported that 88.7% of children in England received the combined Hib/MenC vaccine in 2022-2023, highlighting the growing demand for combination vaccines. This trend is driving the growth of the Pentacel market.
The increasing birth rate is expected to accelerate the growth of the Pentacel market. Higher birth rates can be attributed to factors such as improvements in healthcare, government incentives, and changing societal perspectives. Pentacel is an essential combination vaccine for newborns and young children, offering protection against diphtheria, tetanus, pertussis (whooping cough), poliovirus, and Hib, while minimizing the number of injections required. In 2023, the Australian Bureau of Statistics reported 24,737 births from Aboriginal and Torres Strait Islander populations, marking a rise of 349 babies from the previous year. As birth rates continue to increase, the demand for vaccines such as Pentacel is expected to grow.
The key company operating in the pentacel market is Sanofi Pasteur.
North America was the largest region in the Pentacel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pentacel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pentacel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Pentacel is a combination vaccine that provides protection against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b (Hib). Administered in a four-dose series to children aged 6 weeks to 4 years, it is a part of routine immunization schedules. Pentacel reduces the need for multiple injections, enhancing vaccination compliance and convenience.
The main formulations of Pentacel include the liquid vaccine and the lyophilized vaccine. The Pentacel liquid vaccine combines one of its components, the DTaP-IPV vaccine, in liquid form. Its primary indications include diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, and invasive disease caused by Hib. The vaccine is used by various end users, including healthcare providers, hospitals, and public health programs.
The pentacel market research report is one of a series of new reports that provides pentacel market statistics, including pentacel industry global market size, regional shares, competitors with a pentacel market share, detailed pentacel market segments, market trends, and opportunities, and any further data you may need to thrive in the pentacel industry. This pentacel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pentacel market consists of sales of combination vaccines, vaccine components, and ancillary products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth observed in the historic period can be attributed to several factors, including the rising demand for pediatric vaccines, efforts to reduce the number of injections, increased awareness of vaccine-preventable diseases, government and public health initiatives, and advancements in combination vaccine technology.
The growth anticipated in the forecast period can be attributed to factors such as the expansion of global vaccination coverage, a stronger focus on comprehensive immunization programs, the growing prevalence of vaccine-preventable diseases, technological advancements in vaccine development, and increased government funding and support for childhood immunization. Key trends during this period include the expansion of combination vaccine offerings, the increasing integration of digital health technologies, growing partnerships between pharmaceutical companies and governments, a rise in public-private collaborations for vaccine distribution, and a heightened focus on pediatric healthcare initiatives.
The growing prevalence of tetanus is expected to drive the growth of the Pentacel market. Tetanus cases have been rising due to factors such as insufficient immunization coverage, inadequate wound care, and limited access to healthcare in rural and underserved regions. Pentacel plays a crucial role in preventing tetanus by providing vaccination against the tetanus toxin through its combination of diphtheria, tetanus, and pertussis (DTaP) components, which stimulate the immune system to generate protective antibodies. In 2023, the World Health Organization reported around 21,830 cases of tetanus worldwide, a sharp increase from 6,705 cases in 2022. As a result, the rising prevalence of tetanus is contributing to the growth of the Pentacel market.
The increasing demand for combination vaccines is expected to further fuel the Pentacel market’s growth. Combination vaccines, which combine multiple components into one shot, offer protection against several diseases at once. Their popularity is growing due to the convenience of reducing the number of required injections, improving vaccination adherence, and offering more cost-effective options. Pentacel, as a combination vaccine, provides protection against five diseases, diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib) in a single shot, simplifying the vaccination process for children. In 2023, the UK’s National Health Service reported that 88.7% of children in England received the combined Hib/MenC vaccine in 2022-2023, highlighting the growing demand for combination vaccines. This trend is driving the growth of the Pentacel market.
The increasing birth rate is expected to accelerate the growth of the Pentacel market. Higher birth rates can be attributed to factors such as improvements in healthcare, government incentives, and changing societal perspectives. Pentacel is an essential combination vaccine for newborns and young children, offering protection against diphtheria, tetanus, pertussis (whooping cough), poliovirus, and Hib, while minimizing the number of injections required. In 2023, the Australian Bureau of Statistics reported 24,737 births from Aboriginal and Torres Strait Islander populations, marking a rise of 349 babies from the previous year. As birth rates continue to increase, the demand for vaccines such as Pentacel is expected to grow.
The key company operating in the pentacel market is Sanofi Pasteur.
North America was the largest region in the Pentacel market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pentacel report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the pentacel market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Pentacel is a combination vaccine that provides protection against diphtheria, tetanus, pertussis, poliomyelitis, and Haemophilus influenzae type b (Hib). Administered in a four-dose series to children aged 6 weeks to 4 years, it is a part of routine immunization schedules. Pentacel reduces the need for multiple injections, enhancing vaccination compliance and convenience.
The main formulations of Pentacel include the liquid vaccine and the lyophilized vaccine. The Pentacel liquid vaccine combines one of its components, the DTaP-IPV vaccine, in liquid form. Its primary indications include diphtheria, tetanus, pertussis (whooping cough), poliomyelitis, and invasive disease caused by Hib. The vaccine is used by various end users, including healthcare providers, hospitals, and public health programs.
The pentacel market research report is one of a series of new reports that provides pentacel market statistics, including pentacel industry global market size, regional shares, competitors with a pentacel market share, detailed pentacel market segments, market trends, and opportunities, and any further data you may need to thrive in the pentacel industry. This pentacel market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pentacel market consists of sales of combination vaccines, vaccine components, and ancillary products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Pentacel Market Characteristics4. Pentacel Market Trends and Strategies5. Pentacel Market -Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market7. Global Pentacel Pricing Analysis & Forecasts30. Global Pentacel Market Competitive Benchmarking and Dashboard31. Key Mergers and Acquisitions in the Pentacel Market32. Recent Developments in the Pentacel Market
3. Pentacel Market Biologic Drug Characteristics
6. Global Pentacel Growth Analysis and Strategic Analysis Framework
8. Pentacel Market Segmentation
9. Global Pentacel Epidemiology of Clinical Indications
10. Pentacel Market Regional and Country Analysis
11. Asia-Pacific Pentacel Market
12. China Pentacel Market
13. India Pentacel Market
14. Japan Pentacel Market
15. Australia Pentacel Market
16. South Korea Pentacel Market
17. Western Europe Pentacel Market
18. UK Pentacel Market
19. Germany Pentacel Market
20. France Pentacel Market
21. Eastern Europe Pentacel Market
22. North America Pentacel Market
23. USA Pentacel Market
24. Canada Pentacel Market
25. South America Pentacel Market
26. Middle East Pentacel Market
27. Africa Pentacel Market
28. Pentacel Market Competitive Landscape and Company Profiles
29. Global Pentacel Market Pipeline Analysis
33. Pentacel Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Pentacel Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on pentacel market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for pentacel? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pentacel market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Formulation: Liquid Vaccine; Lyophilized Vaccine2) by Indication: Diphtheria; Tetanus; Pertussis (Whooping Cough); Poliomyelitis; Invasive Disease Due to Hemophilus Influenzae Type B (Hib)
3) by End User: Healthcare Providers; Hospitals; Public Health Programs
Key Companies Mentioned: Sanofi Pasteur
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Sanofi Pasteur
